title: Dormant melanomas or changing nevi?
abstract: The development of new primary melanomas in patients treated with vemurafenib has been reported recently in a study by Perier-Muzet et al. The primary outcome of the study was to describe the dermoscopic changes that prompted excision of those melanomas. However, the crucial point raised by the study is the large number of melanomas that were detected.
authors.affiliation: Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio, Emilia, Italy. Electronic address: g.argenziano@gmail.com.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Argenziano
authors.affiliation: Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio, Emilia, Italy.
authors.forename: Aimilios
authors.initials: A
authors.lastname: Lallas
authors.affiliation: Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio, Emilia, Italy.
authors.forename: Caterina
authors.initials: C
authors.lastname: Longo
authors.affiliation: Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio, Emilia, Italy.
authors.forename: Elvira
authors.initials: E
authors.lastname: Moscarella
authors.affiliation: Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio, Emilia, Italy.
authors.forename: Margherita
authors.initials: M
authors.lastname: Raucci
authors.affiliation: Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio, Emilia, Italy; Department of Dermatology, Medical University of Graz, Graz, Austria.
authors.forename: Iris
authors.initials: I
authors.lastname: Zalaudek
mesh_terms: D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D008545:Melanoma; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000473:pathology*; D012878:Skin Neoplasms; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib
references.citation: J Clin Oncol. 2012 Jul 1;30(19):2375-83
references.pmid: 22614973
references.citation: J Eur Acad Dermatol Venereol. 2013 Jul;27(7):805-14
references.pmid: 23181611
references.citation: N Engl J Med. 2011 Oct 13;365(15):1448-9; author reply 1450
references.pmid: 21995399
references.citation: J Invest Dermatol. 2011 Feb;131(2):542-5
references.pmid: 21068756
references.citation: J Invest Dermatol. 2014 May;134(5):1351-1358
references.pmid: 24304815
references.citation: Am J Dermatopathol. 1995 Feb;17(1):1-6
references.pmid: 7695003
references.citation: Arch Dermatol. 2012 Oct;148(10):1183-5
references.pmid: 22911096
references.citation: Arch Dermatol. 1975 Dec;111(12):1588-90
references.pmid: 1200664
references.citation: Cancer. 1979 Mar;43(3):939-44
references.pmid: 427733